| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
MGTX
Meiragtx Holdings
|
Jul 08, 2026 | BUY |
Strong Buy
+94.2% avg upside
13 analysts
|
$26.00
94.13% Upside
|
+0.0% |
|
UTHR
United Therapeutics
|
Jul 07, 2026 | BUY |
Strong Buy
-22.7% avg upside
26 analysts
|
$704.00
28.74% Upside
|
-3.7% |
|
MIRM
Mirum Pharmaceuticals
|
Jul 07, 2026 | BUY |
Strong Buy
-4.0% avg upside
21 analysts
|
$148.00
21.14% Upside
|
+0.3% |
|
RYTM
Rhythm Pharmaceuticals
|
Jul 07, 2026 | BUY |
Strong Buy
+12.0% avg upside
19 analysts
|
$141.00
30.12% Upside
|
+0.0% |
|
VRDN
Viridian Therapeutics
|
Jun 29, 2026 | BUY |
Strong Buy
+78.3% avg upside
32 analysts
|
$35.00
77.34% Upside
|
+5.1% |
|
IRD
Opus Genetics
|
Jun 23, 2026 | BUY |
Strong Buy
+167.3% avg upside
24 analysts
|
$10.00
155.10% Upside
|
-3.9% |
|
FDMT
4D Molecular Therapeutics
|
May 07, 2026 | BUY |
Strong Buy
+185.6% avg upside
15 analysts
|
$35.00
184.34% Upside
|
+29.8% |
|
EYPT
EyePoint Pharmaceuticals
|
May 07, 2026 | BUY |
Strong Buy
+126.7% avg upside
19 analysts
|
$37.00
151.41% Upside
|
+9.8% |
|
OCUL
Ocular Therapeutix
|
May 05, 2026 | BUY |
Strong Buy
+141.8% avg upside
21 analysts
|
$30.00
194.12% Upside
|
+5.8% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.